{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihv7vdkl44od42ofukqfr5psgcbhudwdo6ilekimhgbgdmj5hdyyy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mltejjyllw22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibmdwgzbna7k3mzlblx7v4vd2hvcplmmlfbbmah52ecatxyumdco4"
    },
    "mimeType": "image/jpeg",
    "size": 284283
  },
  "path": "/news/2026-05-experimental-drug-advanced-kidney-tumors.html",
  "publishedAt": "2026-05-14T13:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly kidney cancer. In the new study, published in Cell Reports Medicine, researchers tested a novel kind of immunotherapy in individuals with different types of cancer.",
  "title": "Experimental drug shrinks advanced kidney tumors, clears cancer in one patient"
}